Hospital
Loyola University Medical Center
Loyola University Medical Center was paid $9.42M by Medicaid between Jan 2018 and Nov 2022, across 290 billing codes. Its largest line is 97110, Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion — 66% of everything it billed.
33Billing provider infoLOYOLA UNIVERSITY MEDICAL CENTER
MAYWOOD, IL 60153
MAYWOOD, IL 60153
33aNPI1376521575assigned 01/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.42M
24GClaims478,813
24DCodes billed290
24AFirst – last monthJan 2018 – Nov 2022
Compared with peers
Next to other General Acute Care Hospital providers in Illinois
Rank by total paid#2 of 129
Median peer was paid$547K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 150,086 | $2.67M | |
| 2019 | 222,484 | $4.49M | |
| 2020 | 102,856 | $2.18M | |
| 2021 | 3,199 | $63K | |
| 2022 | 188 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 66% | 80,567 | 11,774 | $6.22M |
| 97162 | 2.3% | 4,251 | 2,678 | $215K | |
| 90651 | 1.8% | 2,101 | 734 | $173K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.3% | 4,763 | 3,659 | $125K |
| 90670 | 1.2% | 2,523 | 881 | $116K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 7,621 | 2,641 | $106K |
| 90715 | 1.1% | 4,024 | 1,538 | $104K | |
| 97161 | 1.0% | 2,178 | 1,341 | $97K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.0% | 1,347 | 466 | $96K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,450 | 1,350 | $84K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,169 | 3,558 | $81K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 537 | 404 | $78K |
278 more codes
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,404 | $77K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 2,147 | $76K |
| 80053 | Comprehensive metabolic panel | <1% | 27,912 | $75K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 6,076 | $61K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,799 | $60K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 6,089 | $58K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 7,600 | $58K |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 3,289 | $45K |
| 92557 | <1% | 1,049 | $38K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,963 | $37K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,803 | $36K |
| 17110 | <1% | 593 | $35K | |
| 90746 | <1% | 584 | $35K | |
| 90734 | <1% | 1,024 | $34K | |
| 87507 | <1% | 195 | $31K | |
| 97163 | <1% | 439 | $28K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26,935 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,031 | $26K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,039 | $25K |
| 86480 | <1% | 1,154 | $25K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,971 | $24K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,336 | $24K |
| 0002A | <1% | 577 | $22K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 616 | $21K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,282 | $21K |
| 90750 | <1% | 144 | $20K | |
| 87631 | <1% | 416 | $20K | |
| 0001A | <1% | 626 | $19K | |
| 73610 | <1% | 1,102 | $19K | |
| 92567 | <1% | 1,218 | $18K | |
| 73630 | <1% | 1,356 | $18K | |
| 90732 | <1% | 258 | $17K | |
| 83655 | <1% | 3,098 | $17K | |
| 83970 | <1% | 1,266 | $17K | |
| 95117 | <1% | 2,000 | $15K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,097 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,906 | $14K |
| 90662 | <1% | 259 | $13K | |
| 87536 | <1% | 341 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,326 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,590 | $13K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 627 | $12K |
| 73562 | <1% | 971 | $12K | |
| 90710 | <1% | 483 | $11K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 601 | $11K |
| 73030 | <1% | 850 | $11K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 1,674 | $11K |
| 73564 | <1% | 679 | $10K | |
| 77066 | Tomosynthesis, mammo | <1% | 142 | $10K |
| 94375 | <1% | 279 | $10K | |
| 87653 | <1% | 736 | $9K | |
| 80061 | Lipid panel | <1% | 11,859 | $9K |
| 51701 | <1% | 415 | $9K | |
| 92134 | <1% | 1,047 | $9K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 1,454 | $9K |
| 80197 | <1% | 2,467 | $9K | |
| 92083 | <1% | 399 | $9K | |
| 86235 | <1% | 296 | $9K | |
| 73130 | <1% | 791 | $9K | |
| 87799 | <1% | 383 | $9K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,615 | $8K |
| 85610 | <1% | 7,254 | $8K | |
| 82784 | <1% | 1,493 | $8K | |
| 90698 | <1% | 1,637 | $8K | |
| 86780 | <1% | 2,729 | $8K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,325 | $8K |
| 84403 | <1% | 745 | $7K | |
| 92523 | <1% | 457 | $7K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 757 | $7K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 673 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 841 | $7K |
| 90707 | <1% | 360 | $7K | |
| 81003 | <1% | 10,417 | $7K | |
| 73110 | <1% | 559 | $7K | |
| 69210 | <1% | 294 | $7K | |
| 85027 | <1% | 6,944 | $7K | |
| 96409 | <1% | 151 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 7,085 | $6K |
| 83735 | <1% | 5,134 | $6K | |
| 84439 | <1% | 5,531 | $6K | |
| 90685 | <1% | 1,036 | $6K | |
| 86803 | <1% | 1,719 | $6K | |
| 72110 | <1% | 326 | $6K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 870 | $6K |
| 82105 | <1% | 931 | $6K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 321 | $6K |
| 96367 | <1% | 474 | $5K | |
| 90633 | <1% | 758 | $5K | |
| 90716 | <1% | 152 | $5K | |
| 90680 | <1% | 1,200 | $5K | |
| 72100 | <1% | 380 | $5K | |
| 97166 | <1% | 444 | $5K | |
| 73140 | <1% | 619 | $5K | |
| 82570 | <1% | 4,536 | $5K | |
| 90744 | <1% | 917 | $5K | |
| 86038 | <1% | 1,164 | $5K | |
| 73560 | <1% | 523 | $5K | |
| 81001 | <1% | 7,568 | $4K | |
| 87186 | <1% | 1,273 | $4K | |
| 72190 | <1% | 166 | $4K | |
| 0003A | <1% | 103 | $4K | |
| 82607 | <1% | 945 | $4K | |
| 84466 | <1% | 2,381 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 164 | $4K |
| 87340 | <1% | 1,763 | $4K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 3,178 | $4K |
| 83883 | <1% | 569 | $4K | |
| 86706 | <1% | 1,171 | $4K | |
| 80074 | <1% | 481 | $4K | |
| Q2036 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | <1% | 261 | $3K |
| 80076 | <1% | 1,397 | $3K | |
| 86003 | <1% | 379 | $3K | |
| 86832 | <1% | 65 | $3K | |
| 72082 | <1% | 139 | $3K | |
| 84100 | <1% | 3,465 | $3K | |
| 86334 | <1% | 292 | $3K | |
| 20550 | <1% | 122 | $3K | |
| 74018 | <1% | 353 | $3K | |
| 82728 | <1% | 3,350 | $3K | |
| 86787 | <1% | 872 | $3K | |
| 86160 | <1% | 488 | $3K | |
| 0071A | <1% | 71 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 718 | $3K |
| 87581 | <1% | 537 | $3K | |
| 73100 | <1% | 219 | $3K | |
| 81025 | <1% | 4,949 | $3K | |
| 92133 | <1% | 406 | $3K | |
| 90696 | <1% | 449 | $3K | |
| 87486 | <1% | 537 | $3K | |
| 84481 | <1% | 2,267 | $3K | |
| 73620 | <1% | 386 | $3K | |
| 0012A | <1% | 99 | $3K | |
| 83615 | <1% | 3,565 | $3K | |
| 83001 | <1% | 503 | $3K | |
| 0072A | <1% | 56 | $2K | |
| 73502 | <1% | 138 | $2K | |
| 73600 | <1% | 239 | $2K | |
| 86140 | <1% | 2,757 | $2K | |
| 72050 | <1% | 162 | $2K | |
| 96415 | <1% | 160 | $2K | |
| 86704 | <1% | 514 | $2K | |
| 72120 | <1% | 88 | $2K | |
| 87081 | <1% | 2,743 | $2K | |
| 0004A | <1% | 52 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 956 | $2K |
| 83540 | <1% | 2,824 | $2K | |
| 92060 | <1% | 248 | $2K | |
| 73590 | <1% | 201 | $2K | |
| 72040 | <1% | 192 | $2K | |
| 83880 | <1% | 365 | $2K | |
| 86850 | <1% | 1,527 | $2K | |
| 82962 | <1% | 3,250 | $2K | |
| 82746 | <1% | 450 | $2K | |
| 84702 | <1% | 657 | $2K | |
| 87088 | <1% | 590 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 559 | $2K |
| 87070 | <1% | 1,238 | $2K | |
| 84153 | <1% | 327 | $2K | |
| 86901 | <1% | 1,750 | $2K | |
| 97165 | <1% | 200 | $2K | |
| 87808 | <1% | 680 | $2K | |
| 85018 | <1% | 3,326 | $2K | |
| 83037 | <1% | 2,151 | $2K | |
| 29075 | <1% | 34 | $2K | |
| 72170 | <1% | 200 | $1K | |
| 80069 | <1% | 640 | $1K | |
| 0011A | <1% | 87 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 89 | $1K |
| 84156 | <1% | 2,661 | $1K | |
| 82043 | <1% | 2,647 | $1K | |
| 96417 | <1% | 141 | $1K | |
| 86900 | <1% | 1,769 | $1K | |
| 84146 | <1% | 482 | $1K | |
| 85730 | <1% | 836 | $1K | |
| 83718 | <1% | 334 | $1K | |
| 83516 | <1% | 690 | $1K | |
| 11721 | <1% | 60 | $1K | |
| 86580 | <1% | 438 | $1K | |
| 90632 | <1% | 21 | $1K | |
| 96910 | <1% | 262 | $1K | |
| 73090 | <1% | 119 | $995.62 | |
| 86431 | <1% | 679 | $981.29 | |
| 86708 | <1% | 389 | $975.42 | |
| 84165 | <1% | 421 | $968.03 | |
| 96402 | <1% | 107 | $967.15 | |
| 85014 | <1% | 2,434 | $955.27 | |
| 87496 | <1% | 66 | $954.99 | |
| 83020 | <1% | 668 | $942.61 | |
| 87905 | <1% | 735 | $923.59 | |
| 86200 | <1% | 316 | $921.36 | |
| 82950 | <1% | 983 | $893.26 | |
| 77065 | Tomosynthesis, mammo | <1% | 13 | $859.82 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 58 | $859.48 |
| 83721 | <1% | 481 | $824.98 | |
| 99173 | <1% | 134 | $819.85 | |
| 85652 | <1% | 1,625 | $805.01 | |
| 73080 | <1% | 92 | $799.31 | |
| 86800 | <1% | 324 | $773.84 | |
| 85651 | <1% | 1,197 | $717.96 | |
| 93296 | <1% | 36 | $676.08 | |
| 86833 | <1% | 14 | $655.69 | |
| 84425 | <1% | 155 | $649.91 | |
| 84460 | <1% | 928 | $643.97 | |
| 82565 | <1% | 546 | $613.17 | |
| 82550 | <1% | 674 | $609.08 | |
| 84550 | <1% | 981 | $587.63 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 21 | $579.18 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 109 | $576.73 |
| 94760 | <1% | 231 | $546.58 | |
| 86376 | <1% | 377 | $544.04 | |
| 86762 | <1% | 555 | $518.88 | |
| 86225 | <1% | 207 | $518.22 | |
| 0124A | <1% | 12 | $458.68 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 87 | $457.86 |
| 73070 | <1% | 39 | $441.34 | |
| 83690 | <1% | 463 | $435.06 | |
| 92579 | <1% | 20 | $431.03 | |
| 87147 | <1% | 211 | $429.31 | |
| 11102 | <1% | 20 | $428.76 | |
| 87205 | <1% | 752 | $415.84 | |
| 84703 | <1% | 217 | $406.82 | |
| 87634 | <1% | 24 | $404.80 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 67 | $377.83 |
| 84450 | <1% | 657 | $377.10 | |
| 85045 | <1% | 1,103 | $369.50 | |
| 83002 | <1% | 208 | $347.35 | |
| 86592 | <1% | 587 | $339.86 | |
| 86769 | <1% | 27 | $312.60 | |
| 86765 | <1% | 229 | $306.54 | |
| 82947 | <1% | 958 | $297.86 | |
| 70355 | <1% | 22 | $295.59 | |
| 86255 | <1% | 107 | $274.29 | |
| 87497 | <1% | 15 | $244.10 | |
| 81002 | <1% | 329 | $230.62 | |
| 82525 | <1% | 82 | $216.01 | |
| 82465 | <1% | 473 | $210.01 | |
| 84630 | <1% | 90 | $196.28 | |
| 84402 | <1% | 83 | $187.82 | |
| 82248 | <1% | 139 | $165.66 | |
| 73552 | <1% | 17 | $158.09 | |
| 82785 | <1% | 105 | $153.96 | |
| 84445 | <1% | 16 | $144.32 | |
| 84484 | <1% | 106 | $139.08 | |
| 86361 | <1% | 64 | $134.11 | |
| 82951 | <1% | 24 | $129.75 | |
| 85613 | <1% | 67 | $127.35 | |
| 83013 | <1% | 25 | $114.59 | |
| 82103 | <1% | 40 | $96.38 | |
| 80177 | <1% | 26 | $88.92 | |
| 82310 | <1% | 66 | $73.96 | |
| 84590 | <1% | 104 | $72.88 | |
| 81050 | <1% | 111 | $71.68 | |
| 84432 | <1% | 19 | $69.90 | |
| 84446 | <1% | 34 | $51.72 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 61 | $50.19 |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 68 | $46.47 |
| 83014 | <1% | 25 | $45.96 | |
| 84270 | <1% | 12 | $40.95 | |
| 87101 | <1% | 23 | $39.26 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 16 | $31.21 |
| 83010 | <1% | 15 | $30.77 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 486 | $28.37 |
| 86735 | <1% | 13 | $24.89 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,672 | $23.68 |
| 84520 | <1% | 83 | $22.15 | |
| 84305 | <1% | 14 | $22.02 | |
| 82040 | <1% | 30 | $19.71 | |
| 86705 | <1% | 16 | $14.98 | |
| 82150 | <1% | 20 | $9.30 | |
| 82247 | <1% | 14 | $9.08 | |
| 87077 | <1% | 54 | $8.85 | |
| 82952 | <1% | 12 | $5.73 | |
| 90474 | 0% | 116 | $0.00 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 745 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 257 | $0.00 |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 42 | $0.00 |
| 97803 | 0% | 31 | $0.00 | |
| - | Outside state ambulance serv | 0% | 61 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVINCENT, SHAWN (PRESIDENT & CEO)
| Provider | Location | Paid |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | $52.94 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.